Funded Tech Companies
Theraclone Sciences
Theraclone Sciences, based in Seattle, received equity investments through private investors, Canaan Partners and HealthCare Ventures.
Company Overview
Company Name
Theraclone Sciences
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1124 Columbia St. 300
Seattle, WA 98104
USA
Seattle, WA 98104
USA
Phone
Website
Email Address
Company Background Information
Overview
Theraclone Sciences is a discovery-stage biotech developing novel therapeutic antibodies for the treatment of infectious disease and inflammation. Our proprietary discovery platform allows us to comprehensively screen and identify the rare antibodies that select individuals produce to successfully ward off disease.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/8/2015
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Clifford Stocks
Chief Financial Officer
Russ Hawkinson
Chief Scientific Officer
Kristine Swiderek
Company Investors
- Canaan Partners (Wende Hutton)
- HealthCare Ventures (Christopher Mirabelli)
- Arch Venture Partners (Steven Gillis)
- MPM Capital (William Green)
- Versant Ventures
- Amgen Ventures
- Alexandria Venture Investments
- MidCap Financial
- Silicon Valley Bank
- Allegis Capital
- OVP Venture Partners
Browse more funded tech companies:
Share this article
About Our Venture Capital Transactions Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs